Dec-29-20,10:25AM,Bristol Myers' (BMY) Application for UC Drug Validated by EMA
Jan-01-21,11:16AM,Billionaire Izzy Englanders 10 Favorite Stocks Heading Into 2021
Jan-01-21,08:34AM,Bristol-Myers Derivative Is Now Worthless as Key Deadline Passes
Jan-01-21,06:59AM,Bristol Myers Squibb Provides Update on Status of Contingent Value Rights
Jan-04-21,05:23PM,Drugmakers kick off 2021 with 500 U.S. price hikes
Jan-04-21,06:59AM,"European Medicines Agency Validates Bristol Myers Squibbs Application for Opdivo (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma"
Jan-04-21,06:59AM,European Medicines Agency Validates Bristol Myers Squibbs Application for Opdivo (nivolumab) as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy
Jan-04-21,06:59AM,Bristol Myers Squibb to Present at J.P. Morgans 39th Annual Virtual Healthcare Conference
